PT790245E - Guanididas de acido tiofenilalcenilcarboxilico substituidas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como medicamentos que as contenham - Google Patents

Guanididas de acido tiofenilalcenilcarboxilico substituidas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como medicamentos que as contenham Download PDF

Info

Publication number
PT790245E
PT790245E PT97101597T PT97101597T PT790245E PT 790245 E PT790245 E PT 790245E PT 97101597 T PT97101597 T PT 97101597T PT 97101597 T PT97101597 T PT 97101597T PT 790245 E PT790245 E PT 790245E
Authority
PT
Portugal
Prior art keywords
formula
compound
medicament
preparation
treatment
Prior art date
Application number
PT97101597T
Other languages
English (en)
Portuguese (pt)
Inventor
Heinz-Werner Kleemann
Hans-Jochen Lang
Wolfgang Scholz
Albus Dr Udo
Schwark Dr Jan-Robert
Joachim Brendel
Weichert Dr Andreas
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT790245E publication Critical patent/PT790245E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT97101597T 1996-02-15 1997-02-03 Guanididas de acido tiofenilalcenilcarboxilico substituidas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como medicamentos que as contenham PT790245E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19605610A DE19605610A1 (de) 1996-02-15 1996-02-15 Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
PT790245E true PT790245E (pt) 2001-10-30

Family

ID=7785491

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97101597T PT790245E (pt) 1996-02-15 1997-02-03 Guanididas de acido tiofenilalcenilcarboxilico substituidas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como medicamentos que as contenham

Country Status (29)

Country Link
US (1) US5756535A (enExample)
EP (1) EP0790245B1 (enExample)
JP (1) JP4402747B2 (enExample)
KR (1) KR970061887A (enExample)
AR (1) AR005812A1 (enExample)
AT (1) ATE202096T1 (enExample)
AU (1) AU706554B2 (enExample)
BR (1) BR9700990A (enExample)
CA (1) CA2197628C (enExample)
CZ (1) CZ45597A3 (enExample)
DE (2) DE19605610A1 (enExample)
DK (1) DK0790245T3 (enExample)
ES (1) ES2158383T3 (enExample)
GR (1) GR3036122T3 (enExample)
HR (1) HRP970081B1 (enExample)
HU (1) HUP9700437A3 (enExample)
ID (1) ID15889A (enExample)
IL (1) IL120214A (enExample)
MX (1) MX9701163A (enExample)
NO (1) NO315424B1 (enExample)
NZ (1) NZ314230A (enExample)
PL (1) PL318412A1 (enExample)
PT (1) PT790245E (enExample)
RU (1) RU2193033C2 (enExample)
SI (1) SI0790245T1 (enExample)
SK (1) SK282440B6 (enExample)
TR (1) TR199700109A2 (enExample)
TW (1) TW445261B (enExample)
ZA (1) ZA971260B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19634229A1 (de) * 1996-08-23 1998-02-26 Basf Ag Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
AU4360200A (en) 1999-04-23 2000-11-10 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
PL217872B1 (pl) 2001-10-19 2014-08-29 Toyama Chemical Co Ltd Pochodna eteru alkilowego lub jej sól, stanowiąca 1-{3-[2-(1-benzotiofen-5-ylo)etoksy]propylo}-3-azetydynol lub jego sól

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
GB9012252D0 (en) * 1990-06-01 1990-07-18 Lilly Industries Ltd Pharmaceutical compounds
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4402057A1 (de) * 1994-01-25 1995-08-03 Hoechst Ag Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
TR199700109A2 (tr) 1997-09-21
HUP9700437A3 (en) 2000-03-28
JP4402747B2 (ja) 2010-01-20
SI0790245T1 (en) 2001-08-31
PL318412A1 (en) 1997-08-18
SK282440B6 (sk) 2002-02-05
AR005812A1 (es) 1999-07-14
EP0790245B1 (de) 2001-06-13
US5756535A (en) 1998-05-26
JPH09249660A (ja) 1997-09-22
SK21397A3 (en) 1997-09-10
DK0790245T3 (da) 2001-09-03
GR3036122T3 (en) 2001-09-28
ATE202096T1 (de) 2001-06-15
BR9700990A (pt) 1998-09-01
AU1265997A (en) 1997-08-21
EP0790245A1 (de) 1997-08-20
HRP970081B1 (en) 2003-04-30
RU2193033C2 (ru) 2002-11-20
IL120214A (en) 2000-08-31
HU9700437D0 (en) 1997-04-28
NO970697L (no) 1997-08-18
CZ45597A3 (en) 1997-09-17
NZ314230A (en) 1997-12-19
CA2197628A1 (en) 1997-08-16
HUP9700437A2 (hu) 1998-08-28
KR970061887A (ko) 1997-09-12
ID15889A (id) 1997-08-14
MX9701163A (es) 1997-08-30
NO315424B1 (no) 2003-09-01
ZA971260B (en) 1997-08-15
CA2197628C (en) 2006-05-16
IL120214A0 (en) 1997-06-10
HRP970081A2 (en) 1998-04-30
DE19605610A1 (de) 1997-08-21
TW445261B (en) 2001-07-11
DE59703746D1 (de) 2001-07-19
ES2158383T3 (es) 2001-09-01
NO970697D0 (no) 1997-02-14
AU706554B2 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
JP3802582B2 (ja) ペルフルオロアルキル−置換ベンゾイルグアニジン類、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬
NO179946B (no) Benzoylguanidiner og deres anvendelse som medikamenter
PT659748E (pt) 1,1-dioxido-2h-1,2-benzotiazinoilguanidina substituidas, processo para a sua preparacao, sua utilizacao como medicamento ou meio de diagnostico bem como medicamento que as contem.
MXPA97006380A (en) Guarides of alkenil-carboxylic acids replaced with phenyl, procedures for preparation, use as a medicine or diagnostic agent, as well as a medication that contains them
CN1062858C (zh) 含氟的苯基取代链烯羧酰胍、制法、药用及其药品
RU2164913C2 (ru) Гуанидиды алкенилкарбоновых кислот, способ их получения, способ ингибирования клеточного na+/h+-обмена и фармацевтическая композиция
NO300590B1 (no) Substituerte benzoylguanidiner, deres anvendelse til fremstilling av medikamenter såvel som medikamenter som inneholder dem
AU704461B2 (en) Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents and medicaments comprising them
NO300264B1 (no) Substituerte benzoylguanidiner, deres anvendelse som medikament samt medikament inneholdende disse
HU217628B (hu) Karbamiddal helyettesített benzoilguanidinszármazékok, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények
ES2210872T5 (es) Acilguanidinas.
CA2206366C (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
HU217617B (hu) Perfluor-alkil-csoportot hordozó fenil-alkil-karbonsav-guanidin-származékok, eljárás előállításukra és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
PT790245E (pt) Guanididas de acido tiofenilalcenilcarboxilico substituidas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como medicamentos que as contenham
JP4101904B2 (ja) オルト−置換されたベンゾイルグアニジン、その製法、医薬または診断剤としてのその使用およびそれを含有する医薬
RU2159762C2 (ru) Замещенные бензоилгуанидины, способ их получения, способ ингибирования и фармацевтический препарат
RU2182901C2 (ru) Замещенные 1-нафтоилгуанидины и лекарственное средство на их основе
KR100498799B1 (ko) 오르토-치환된벤조일구아니딘,이의제조방법및이를포함하는약제학적조성물
RU2161604C2 (ru) Замещенные основанием бензоилгуанидины, способ их получения, фармацевтический состав, способ его получения и способ ингибирования клеточного na+/h+-антипортера